Internal Server Error

BioSymetrics - About the company

BioSymetrics is a series A company based in New York City (United States), founded in 2015 by Anthony Iacovone. It operates as a Provider of a cognitive computing-based biomedical intelligence platform. BioSymetrics has raised $4.88M in funding. The company has 145 active competitors, including 63 funded and 8 that have exited. Its top competitors include companies like Insitro, DNAnexus and Atomwise.

Company Details

Provider of a cognitive computing-based biomedical intelligence platform. It provides pre-processing, analytics and zero-latency machine learning for cases in bioinformatics, R&D clinical informatics, target discovery, and computational biology. It also provides predictive analytics on many kinds of R&D and healthcare data.
Social
X
Email ID
*****@BioSymetrics.com
Phone Number
+1 **********
Key Metrics
Founded Year
2015
Location
New York City, United States
Stage
Series A
Total Funding
$4.88M in 2 rounds
Investors
Ranked
Employee Count
12 as on Sep 30, 2026
Similar Companies
Sign up to download BioSymetrics' company profile

BioSymetrics's funding and investors

BioSymetrics has raised a total funding of $4.88M over 2 rounds. Its first funding round was on Aug 04, 2021. Its latest funding round was a Grant (prize money) round on Jul 23, 2025 for $*****. 1 investor participated in its latest round. BioSymetrics has 4 institutional investors.

Here is the list of recent funding rounds of BioSymetrics:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 23, 2025
5872398
Grant (prize money)
5712756
9235951
3814800
9230330
Aug 04, 2021
3646109
Series A
7531172
2998024
6104105
2264476
lockAccess funding benchmarks and valuations. Sign up today!

BioSymetrics' founders and board of directors

Founder? Claim Profile
The founders of BioSymetrics is Anthony Iacovone.
Here are the details of BioSymetrics' key team members:

BioSymetrics' employee count trend

BioSymetrics has 12 employees as of Sep 26. Here is BioSymetrics's employee count trend over the years:
Employee count trend for BioSymetrics
lockUncover BioSymetrics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

BioSymetrics's Competitors and alternates

Top competitors of BioSymetrics include Insitro, DNAnexus and Atomwise. Here is the list of Top 10 competitors of BioSymetrics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Insitro
Insitro
2018, San Francisco (United States), Series C
Developer of machine learning platform for drug discovery and development
$643M
70/100
2nd
Logo for DNAnexus
DNAnexus
2009, Mountain View (United States), Series H
Provider of cloud-based genome informatics & data management platform
$473M
70/100
3rd
Logo for Atomwise
Atomwise
2012, San Francisco (United States), Series B
Developer of artificial intelligence platform for small molecule drug discovery
$219M
67/100
4th
Logo for Antiverse
Antiverse
2017, Cardiff (United Kingdom), Series A
Developer of computational platform for de novo design of antibody therapeutics
$20M
67/100
5th
Developer of next-generation of immunomodulatory therapeutics
$295M
65/100
6th
Logo for Asimov
Asimov
2017, Boston (United States), Series B
Provider of integrated suite for advanced genetic design and manufacturing
$234M
65/100
7th
Logo for Cytel
Cytel
1987, Cambridge (United States), Acquired
Provider of data analysis and statistical solutions for the life sciences industry
$2M
65/100
8th
Logo for Metagenomi
Metagenomi
2016, Berkeley (United States), Public
Digital gene editing technologies for drug development
$376M
64/100
9th
Logo for Relation
Relation
2019, London (United Kingdom), Seed
AI-based drug development tools for researchers
$116M
64/100
10th
Logo for Somite
Somite
2023, Boston (United States), Series A
AI-driven platform to produce human tissue for cell-based therapies
$60M
63/100
50th
Logo for BioSymetrics
BioSymetrics
2015, New York City (United States), Series A
Provider of a cognitive computing-based biomedical intelligence platform
$4.88M
39/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on BioSymetrics's competitors? Click here to see the top ones

BioSymetrics's Investments and acquisitions

BioSymetrics has made no investments or acquisitions yet.

Reports related to BioSymetrics

Here is the latest report on BioSymetrics's sector:

News related to BioSymetrics

lockFilter this list
•
•
Dr. Calum MacRae to Become Senior Advisor to BioSymetricsBioSpace•Feb 07, 2019•BioSymetrics
•
BioSymetrics Announces Strategic Advisory BoardBusiness Wire•Jul 24, 2018•BioSymetrics
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about BioSymetrics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford